ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184. Rong Z, Xing J, Wu L, Zheng K, et al. Br J Cancer 2026 Jan 13. doi: 10.1038/s41416-025-03223.

Read + Share

Amedeo Smart

Independent Medical Education

Rong Z, Xing J, Wu L, Zheng K, et al. ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184. Br J Cancer 2026 Jan 13. doi: 10.1038/s41416-025-03223.
PMID: 41530575